Copertina

Impact of Glucagon‐Like Peptide‐1 Receptor Agonists on Proteinuria in Kidney Transplant Recipients

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Stephanie Shabanowitz, Ryan Clark, Rachel Bassett Allen, Mary Chandran, Anita Yang
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2026
Soggetti:	Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

SGLT2 Inhibitors and GLP‐1 Receptor Agonists After Acute Kidney Injury: A Systematic Review With Meta‐Analysis
di: Erin F. Barreto, et al.
Pubblicazione: (2026)

Real‐World Cardiovascular Outcomes of GLP ‐1 Receptor Agonists in Women With Type 2 Diabetes and Breast Cancer
di: Cyrille K. Cornelio, et al.
Pubblicazione: (2026)

Beyond Monotherapy: The Superior Efficacy of Combined GLP ‐1 Receptor Agonist and SGLT2 Inhibitors on Renal Biomarkers: A Systematic Review and Meta‐Analysis
di: Aya M. AbdelMagid, et al.
Pubblicazione: (2026)

Thromboembolic Risk of Thrombopoietin Receptor Agonists for Adult Primary Immune Thrombocytopenia: A Systematic Review and Meta‐Analysis Integrating Randomized Controlled Trials and Prospective Evidence
di: Meng‐Fei Dai, et al.
Pubblicazione: (2025)

Kidney Damage Biomarkers: A Missing Piece of the Diagnostic and Management Puzzle for Acute Drug‐Related Kidney Diseases
di: Sandra L. Kane‐Gill
Pubblicazione: (2025)

Updates in chronic kidney disease management: A systematic review
di: Amina Ammar, et al.
Pubblicazione: (2025)

Incidence of Acute Kidney Injury With the Use of Nafcillin Versus Oxacillin
di: Alejandro D. Perez, et al.
Pubblicazione: (2026)

Retrospective cohort study of oral switch versus intravenous antibiotics for carbapenem‐resistant enterobacterales and Pseudomonas aeruginosa infections on hospital discharge
di: Christen J. Arena, et al.
Pubblicazione: (2025)

Association of Human Leucocyte Antigen with Tacrolimus Pharmacokinetics in Renal Transplant Patients
di: Rashmi J. Hemani, et al.
Pubblicazione: (2026)

Impacts of age and BMI on vancomycin model choice in a Bayesian software: Lessons from a very large multi‐site retrospective study
di: Maria‐Stephanie A. Hughes, et al.
Pubblicazione: (2024)

High‐Throughput Screening for Prescribing Cascades Among Real‐World Angiotensin‐ II Receptor Blockers ( ARBs ) Initiators
di: Asinamai M. Ndai, et al.
Pubblicazione: (2025)

Synthetic Data–Driven Early Prediction Framework for Acute Kidney Injury in Patients Receiving Vancomycin and Ceftazidime/Avibactam
di: Maryam Ramazani, et al.
Pubblicazione: (2025)

Hyperfiltration in Critically Ill Older Adults: Incidence, Risk Factors, Time Course, and Predictive Performance of Kidney Function Estimation
di: Ryusei Mikami, et al.
Pubblicazione: (2026)

Comparison of Subcutaneous Versus Intravenous Filgrastim in Autologous Hematopoietic Stem Cell Transplantation: A Retrospective Study
di: Glenn Chang, et al.
Pubblicazione: (2025)

Utilizing Machine Learning to Identify Predictors of Corticosteroid Discontinuation 1‐Year After Adult Heart Transplant
di: Caroline Chen, et al.
Pubblicazione: (2025)

Association of Pneumonia, Fracture, Metabolic, and Renal Events With Long‐Term Proton Pump Inhibitor Use in Patients With Chronic Kidney Disease
di: Yi‐Fan Chien, et al.
Pubblicazione: (2025)

Cross‐titration from risperidone to clozapine utilizing clozapine serum concentrations: A case report
di: Nicolette Centanni, et al.
Pubblicazione: (2025)

Effect of creatine monohydrate on motor function in children with facioscapulohumeral muscular dystrophy: A multicenter, randomized, double‐blind placebo‐controlled crossover trial
di: Ian R. Woodcock, et al.
Pubblicazione: (2025)

Immune Checkpoint Inhibitor Exposure During Pregnancy: A Systematic Review
di: Casey L. Keller, et al.
Pubblicazione: (2026)

Impact of Dosing Interval Adherence on Pharmacokinetic Outcomes of Recombinant Erwinia Asparaginase in Pediatric Leukemia or Lymphoma
di: Milre M. Matherne, et al.
Pubblicazione: (2026)

Disease‐modifying therapies for amyloid transthyretin cardiomyopathy: Current and emerging medications
di: Erika L. Hellenbart, et al.
Pubblicazione: (2024)

Machine Learning Algorithms for Predicting Injurious Fall Risk Among Older Adults With Depression: A Prognostic Modeling Study
di: Grace Hsin‐Min Wang, et al.
Pubblicazione: (2025)

Scoping review of drug dosing recommendations in sustained low‐efficiency dialysis
di: Nicholas R. Nelson, et al.
Pubblicazione: (2024)

Corticosteroids in critically ill patients: A narrative review
di: Bradley J. Haan, et al.
Pubblicazione: (2024)

Pharmacokinetic and pharmacodynamic evaluation of sulbactam‐durlobactam in a critically ill patient on continuous venovenous hemofiltration infected with carbapenem‐resistant Acinetobacter baumannii‐calcoaceticus complex
di: Wesley D. Kufel, et al.
Pubblicazione: (2025)

Multicenter study evaluating target attainment of anti‐Factor Xa levels using various enoxaparin prophylactic dosing practices in adult trauma patients
di: Tyler Chanas, et al.
Pubblicazione: (2024)

Evaluation of methotrexate Pharmacogenomic variation to predict acute neurotoxicity in children with acute lymphoblastic leukemia
di: Rachel D. Harris, et al.
Pubblicazione: (2024)

Vancomycin: An analysis and evaluation of eight population pharmacokinetic models for clinical application in general adult population
di: Alexandre Duong, et al.
Pubblicazione: (2024)

Thrombosis Across Female‐Specific Malignancies: From Chemotherapy‐Driven Risk to Prophylaxis and Drug Interactions
di: Maryam Aghakouchakzadeh, et al.
Pubblicazione: (2026)

Cancer Treatment Modalities and Female Fertility Preservation
di: Seonga Song, et al.
Pubblicazione: (2026)

Aztreonam–avibactam: The dynamic duo against multidrug‐resistant gram‐negative pathogens
di: Mohammed Al Musawa, et al.
Pubblicazione: (2024)

Response to comment on “Intravenous ketamine successfully treats treatment‐resistant catatonia in schizophrenia: A case report”
di: Atif Siddiqui
Pubblicazione: (2025)

Managing attention‐deficit/hyperactivity disorder in a breastfeeding mother: A case report
di: Jiwon Kim, et al.
Pubblicazione: (2025)

Effect of proton pump inhibitors versus histamine‐2 receptor antagonists on acute kidney injury in septic patients at high risk for developing stress ulcers
di: Hua‐Ping Fan, et al.
Pubblicazione: (2024)

Pharmacokinetic and Pharmacodynamic Principles and Concepts Remain Relevant in the Era of Artificial Intelligence and Machine Learning
di: Keith A. Rodvold
Pubblicazione: (2026)

Developing a Statistical Modeling‐Based Machine Learning Approach for Capturing Drug Dosing Using a Proton Pump Inhibitor Case
di: Amanda Massmann, et al.
Pubblicazione: (2025)

In Search of Big Beautiful Biomarkers
di: C. Lindsay DeVane
Pubblicazione: (2025)

“Comment on ‘international consensus recommendations for the use of prolonged‐infusion β‐lactams endorsed by the American College of Clinical Pharmacy (ACCP), the British Society for Antimicrobial Chemotherapy (BSAC), the Cystic Fibrosis Foundation (CFF), the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), the infectious diseases Society of American (IDSA), the Society of Critical Care Medicine (SCCM), and the Society of Infectious Diseases Pharmacists’”
di: Carlos Augusto Espinoza Cobeñas
Pubblicazione: (2024)

Response to comment on “International consensus recommendations for the use of prolonged‐infusion β‐lactams endorsed by the American College of Clinical Pharmacy (ACCP), the British Society for Antimicrobial Chemotherapy (BSAC), the Cystic Fibrosis Foundation (CFF), the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), the Infectious Diseases Society of American (IDSA), the Society of Critical Care Medicine (SCCM), and the Society of Infectious Diseases Pharmacists”
di: Lisa T. Hong, et al.
Pubblicazione: (2024)

Genome‐wide associations with metabolic syndrome among UK Biobank participants reporting use of second‐generation antipsychotics
di: Nihal El Rouby, et al.
Pubblicazione: (2025)